Literature DB >> 12949354

Leptin and insulin modulate nutrient partitioning and weight loss in ob/ob mice through regulation of long-chain fatty acid uptake by adipocytes.

Xinqing Fan1, Michael W Bradbury, Paul D Berk.   

Abstract

Leptin treatment of ob/ob mice leads to weight loss appreciably greater than that in pair-fed mice. To test whether this "extra" weight loss is mediated by leptin-induced alterations in nutrient partitioning, the effects in ob/ob mice of subcutaneous leptin infusion (500 ng/h for <or=21 d) on adipocyte fatty acid uptake and transporter gene expression were examined. Mice were initially hyperinsulinemic (5.25 +/- 1.57 nmol/L). Plasma insulin decreased by 55 +/- 10% within 8 h of leptin infusion, declining progressively to normal by d 14. The V(max) for saturable adipocyte fatty acid uptake fell from 31.1 +/- 5.6 to 25.2 +/- 4.0 pmol/(s. 50000 cells) (P < 0.05) by 24 h, and to a normal rate (8.0 +/- 0.8 pmol/(s. 50000 cells) by d 21 (P > 0.5 vs. normal C57BL/6J controls). Adipocyte mRNA levels for plasma membrane fatty acid binding protein and fatty acid translocase, putative fatty acid transporters that are up-regulated three- to fourfold in adipocytes from ob/ob mice, had also normalized by d 21. The initial changes in V(max) preceded decreases in food intake and body weight by at least 24 h. In pair-fed mice, insulin levels, V(max) and body weight all declined more slowly than in leptin-treated mice, and all remained significantly elevated compared with normal values at d 21. The data suggest that insulin up-regulates and leptin down-regulates adipocyte fatty acid uptake, leading to alterations in fatty acid partitioning that affect adiposity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949354     DOI: 10.1093/jn/133.9.2707

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

Review 1.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

2.  Molecular modeling and functional confirmation of a predicted fatty acid binding site of mitochondrial aspartate aminotransferase.

Authors:  Michael W Bradbury; Decherd Stump; Frank Guarnieri; Paul D Berk
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

3.  Adipocyte Size and Leptin Receptor Expression in Human Subcutaneous Adipose Tissue After Roux-en-Y Gastric Bypass.

Authors:  Martha Tamez; Victoria Ramos-Barragan; Patricia Mendoza-Lorenzo; Pablo Arrieta-Joffe; Sergio López-Martínez; Martín E Rojano-Rodríguez; Mucio Moreno-Portillo; María E Frigolet
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

Review 4.  Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance.

Authors:  Paul D Berk; Elizabeth C Verna
Journal:  Clin Liver Dis       Date:  2016-02-18       Impact factor: 6.126

5.  Adipocyte accumulation of long-chain fatty acids in obesity is multifactorial, resulting from increased fatty acid uptake and decreased activity of genes involved in fat utilization.

Authors:  José L Walewski; Fengxia Ge; Michel Gagner; William B Inabnet; Alfons Pomp; Andrea D Branch; Paul D Berk
Journal:  Obes Surg       Date:  2009-10-29       Impact factor: 4.129

6.  Facilitated long chain fatty acid uptake by adipocytes remains upregulated relative to BMI for more than a year after major bariatric surgical weight loss.

Authors:  Fengxia Ge; José L Walewski; Mehyar Hefazi Torghabeh; Harrison Lobdell; Chunguang Hu; Shengli Zhou; Gregory Dakin; Alfons Pomp; Marc Bessler; Beth Schrope; Aku Ude-Welcome; William B Inabnet; Tianshu Feng; Elektra Carras-Terzian; Dieunine Anglade; Faith E Ebel; Paul D Berk
Journal:  Obesity (Silver Spring)       Date:  2015-11-20       Impact factor: 5.002

7.  Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity.

Authors:  José L Walewski; Fengxia Ge; Harrison Lobdell; Nancy Levin; Gary J Schwartz; Joseph R Vasselli; Afons Pomp; Gregory Dakin; Paul D Berk
Journal:  Obesity (Silver Spring)       Date:  2014-03-08       Impact factor: 5.002

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.